{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:45:30Z","timestamp":1790736330742,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574278"],"award-info":[{"award-number":["82574278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003512","name":"State Administration of Foreign Experts Affairs","doi-asserted-by":"publisher","award":["B18056"],"award-info":[{"award-number":["B18056"]}],"id":[{"id":"10.13039\/501100003512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017534","name":"Project 333 of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017534","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018925","name":"Overseas Expertise Introduction Center for Discipline Innovation of Food Nutrition and Human Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.118925","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T23:25:34Z","timestamp":1778196334000},"page":"118925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis and anti-necroptosis evaluation of RIPK1 inhibitors derived from sunitinib"],"prefix":"10.1016","volume":"315","author":[{"given":"Yuhan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiting","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5044-3721","authenticated-orcid":false,"given":"Xiaobing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118925_bib1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.118925_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118925_bib3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: an ordered cellular explosion","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.118925_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nature13706","article-title":"RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis","volume":"513","author":"Takahashi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118925_bib5","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","article-title":"Receptor interacting protein kinase\u20133 determines cellular necrotic response to TNF\u2013alpha","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118925_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","article-title":"Mixed lineage kinase domain\u2013like protein mediates necrosis signaling downstream of RIP3 kinase","volume":"148","author":"Sun","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118925_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118925_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","article-title":"Necroptosis and RIPK1\u2013mediated neuroinflammation in CNS diseases","volume":"20","author":"Yuan","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118925_bib9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1146\/annurev-biochem-060815-014830","article-title":"Necroptosis and inflammation","volume":"85","author":"Newton","year":"2016","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2026.118925_bib10","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1021\/acs.jmedchem.6b01751","article-title":"Discovery of a First\u2013in\u2013Class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases","volume":"60","author":"Harris","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118925_bib11","article-title":"Potent and selective RIPK1 inhibitors targeting dual\u2013pockets for the treatment of systemic inflammatory response syndrome and sepsis","volume":"61","author":"Yang","year":"2022","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118925_bib12","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/acs.jmedchem.9b01317","article-title":"Small\u2013molecule inhibitors of necroptosis: current status and perspectives","volume":"63","author":"Zhuang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118925_bib13","doi-asserted-by":"crossref","first-page":"9714","DOI":"10.1073\/pnas.1901179116","article-title":"Targeting RIPK1 for the treatment of human diseases","volume":"116","author":"Degterev","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2026.118925_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tips.2020.01.002","article-title":"Inhibitors targeting RIPK1\/RIPK3: old and new drugs","volume":"41","author":"Martens","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.118925_bib15","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1021\/acs.jmedchem.7b01449","article-title":"Tozasertib analogues as inhibitors of necroptotic cell death","volume":"61","author":"Hofmans","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118925_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.130","article-title":"A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis","volume":"6","author":"Fauster","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.118925_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.298","article-title":"Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury","volume":"8","author":"Martens","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.118925_bib18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/cdd.2017.58","article-title":"When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157","volume":"24","author":"Rojas\u2013Rivera","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.118925_bib19","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.celrep.2015.02.052","article-title":"Structure guided design of potent and selective ponatinib\u2013based hybrid inhibitors for RIPK1","volume":"10","author":"Najjar","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2026.118925_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.365","article-title":"Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers","volume":"5","author":"Weisel","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ejmech.2026.118925_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2015.9","article-title":"Characterization of GSK'963: a structurally distinct, potent and selective inhibitor of RIP1 kinase","volume":"1","author":"Berger","year":"2015","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejmech.2026.118925_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41418-019-0347-0","article-title":"RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases","volume":"27","author":"Patel","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.118925_bib23","article-title":"Discovery of novel hydroxyamidine based indoleamine 2,3\u2013dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors","volume":"245","author":"Zhou","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118925_bib24","doi-asserted-by":"crossref","first-page":"17319","DOI":"10.1021\/acs.jmedchem.4c01223","article-title":"Discovery of novel PROTAC SIRT6 degraders with potent efficacy against hepatocellular carcinoma","volume":"67","author":"Huang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118925_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113091","article-title":"Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion","volume":"211","author":"Qiu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118925_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1358\/dot.2006.42.6.985633","article-title":"Sunitinib: a newly approved small\u2013molecule inhibitor of angiogenesis","volume":"42","author":"Cabebe","year":"2006","journal-title":"Drugs Today"},{"key":"10.1016\/j.ejmech.2026.118925_bib27","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"11","author":"Davis","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.118925_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101150","article-title":"O\u2013GlcNAcylation regulation of RIPK1\u2013dependent apoptosis dictates sensitivity to sunitinib in renal cell carcinoma","volume":"77","author":"Zeng","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2026.118925_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbrc.2007.02.156","article-title":"Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor","volume":"356","author":"Roskoski","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.118925_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ncb2883","article-title":"Plasma membrane translocation of trimerized MLKL protein is required for TNF\u2013induced necroptosis","volume":"16","author":"Cai","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.118925_bib35","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1084\/jem.187.9.1477","article-title":"Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor","volume":"187","author":"Vercammen","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejmech.2026.118925_bib36","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3390\/molecules30081821","article-title":"Combination treatment of timosaponin BII and pirfenidone attenuated pulmonary fibrosis through anti\u2013inflammatory and anti\u2013fibrotic process in rodent pulmonary fibrosis model and cellular epithelial\u2013mesenchymal transition model","volume":"30","author":"Shen","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118925_bib38","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118925_bib39","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1021\/acs.orglett.3c00885","article-title":"Synthesis of cyclohepta[b]indoles and Furo[3,4\u2013b] carbazoles from indoles, tertiary propargylic alcohols, and activated alkynes","volume":"25","author":"Yin","year":"2023","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.118925_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/cr.2013.171","article-title":"Translocation of mixed lineage kinase domain\u2013like protein to plasma membrane leads to necrotic cell death","volume":"24","author":"Chen","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2026.118925_bib32","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/cdd.2012.133","article-title":"Activity and specificity of necrostatin\u20131, small\u2013molecule inhibitor of RIP1 kinase","volume":"20","author":"Degterev","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.118925_bib33","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.immuni.2011.09.020","article-title":"RIP kinase\u2013dependent necrosis drives lethal systemic inflammatory response syndrome","volume":"35","author":"Duprez","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2026.118925_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1310050","volume":"370","author":"Linkermann","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.118925_bib37","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:04:11Z","timestamp":1783199051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426003703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"alternative-id":["S0223523426003703"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118925","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and anti-necroptosis evaluation of RIPK1 inhibitors derived from sunitinib","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118925"}}